Core Points - Columbia Banking System, Inc. announced a quarterly cash dividend of $0.37 per common share, marking a 3% increase from the previous dividend declaration [1][2] - The dividend is scheduled to be paid on December 15, 2025, to shareholders of record as of November 28, 2025 [1] - The company also revealed a $700 million share repurchase program, indicating a strong commitment to returning capital to shareholders [2] Company Overview - Columbia Banking System, Inc. is headquartered in Tacoma, Washington, and is the parent company of Columbia Bank, which is the largest bank in the Northwest and one of the largest in the West [2] - Columbia Bank offers a comprehensive range of services, including retail and commercial banking, SBA lending, corporate banking, and wealth management [2] - The company emphasizes its commitment to delivering superior, personalized service while combining the resources of a national bank [2]

Core Points - Crédit Agricole S.A. has decided to reduce its share capital by cancelling 22,886,191 treasury shares, which represents approximately 0.75% of the total share capital [1][2] - The cancellation of shares is effective from 13 November 2025, following the authorization from the General Meeting of Shareholders on 22 May 2024 [1] - After the cancellation, the total share capital of Crédit Agricole S.A. will amount to 9,077,707,050 euros, consisting of 3,025,902,350 shares, with 583,317 treasury shares remaining under a liquidity agreement [3] Share Repurchase Program - The treasury shares were acquired under a share repurchase program conducted between 1 October 2025 and 30 October 2025, aimed at offsetting the dilutive effect of a capital increase reserved for employees [2] - The total expenditure for the share repurchase program was 374,414,014 euros, as decided by the Board of Directors on 14 May 2025 [2]

Core Points - Crédit Agricole S.A. has decided to reduce its share capital by cancelling 22,886,191 treasury shares, which represents approximately 0.75% of the total share capital [1] - The cancellation of shares is effective from 13 November 2025, following the authorization from the General Meeting of Shareholders held on 22 May 2024 [1] - The shares were repurchased under a program conducted between 1 October 2025 and 30 October 2025, with a total expenditure of 374,414,014 euros, aimed at offsetting the dilutive effect of a capital increase reserved for employees [2] - After the cancellation, Crédit Agricole S.A.'s share capital will amount to 9,077,707,050 euros, consisting of 3,025,902,350 shares, including 583,317 treasury shares held under a liquidity agreement [3]

Core Viewpoint - Primo Brands Corporation has authorized an increase of $50 million to its existing share repurchase program, raising the total authorization to $300 million [1][2]. Share Repurchase Program - The company has previously repurchased approximately 4.4 million shares of Class A common stock for about $97.7 million, leaving approximately $202.3 million of capacity under the repurchase program after the increase [2][3]. - The repurchase may occur through various methods including open market purchases, block trades, and privately negotiated transactions, with management having discretion over the timing and amount based on market conditions [3]. Company Overview - Primo Brands is a leading North American branded beverage company focused on healthy hydration, offering a diverse range of products distributed across the U.S. and Canada [4]. - The company has a comprehensive portfolio that includes well-known brands such as Poland Spring® and Pure Life®, as well as premium and regional offerings [4]. - Primo Brands operates a vertically integrated distribution network reaching over 200,000 retail outlets and provides direct delivery services to homes and businesses [4]. - The company emphasizes sustainability through reusable packaging and actively manages water resources, conserving over 28,000 acres of land [4].

Core Insights - Energy Recovery's shares fell 11.6% following the release of disappointing earnings despite beating revenue and EPS estimates [1] - The company reported revenue of $32 million, a 17.1% decline year-over-year, and adjusted EPS of $0.12, surpassing the forecast of $0.10 [1] - Adjusted EBITDA of $6.8 million missed analyst expectations, and operating margin decreased to 11.4% from 18.3% year-over-year, raising investor concerns [1] Financial Performance - Revenue of $32 million exceeded the consensus estimate of $29.94 million but represented a significant decline from the previous year [1] - Adjusted EPS of $0.12 was above the forecast of $0.10, indicating some positive performance on the bottom line [1] - Adjusted EBITDA of $6.8 million fell short of analyst estimates, highlighting underlying weaknesses in profitability [1] Market Reaction - The stock experienced significant volatility, with 11 moves greater than 5% in the past year, indicating a strong market reaction to recent news [3] - The recent drop in share price reflects a shift in market perception regarding the company's performance and future prospects [3] Historical Context - The stock had previously gained 8.4% three months ago following the announcement of a $25 million share repurchase program, reflecting management's confidence in growth and cash generation [4] - The total share repurchase program reached $105 million over the past year, indicating a commitment to returning value to shareholders [4] Current Valuation - Energy Recovery's stock is trading at $14.99 per share, which is 24.8% below its 52-week high of $19.93 from November 2024 [5] - An investment of $1,000 in Energy Recovery's shares five years ago would now be worth $1,496, showing a moderate growth trajectory over the long term [5]

Core Viewpoint - Niagen Bioscience, Inc. has announced a share repurchase program authorized by its Board of Directors, allowing the company to repurchase up to $10 million of outstanding common stock over approximately 24 months [1] Company Summary - Niagen Bioscience, Inc. is recognized as a global authority on NAD+ (nicotinamide adenine dinucleotide) and focuses on the science of healthy aging [1] - The company expresses confidence in its investment potential, describing the share repurchase program as a compelling opportunity [1]

Core Insights - The company reported record quarterly revenue of $260.5 million, reflecting a 9.3% year-over-year increase driven by 7.6% organic growth [1][4] - Net income reached $47.2 million, or $1.01 per diluted share, marking the second most profitable quarter in the company's history [1][8] - The company announced an expansion of its share repurchase program to $150 million, supported by a strong balance sheet and total liquidity of $550 million [1][13][14] Financial Performance - Total revenues for Q3 2025 increased by 9.3% compared to Q3 2024, with multi-family/commercial revenues growing by 14.3% and single-family residential revenues increasing by 3.4% [4][5] - Gross profit for the quarter was $111.3 million, representing a gross margin of 42.7%, down from 45.8% in the prior year due to unfavorable revenue mix and higher raw material costs [6] - Adjusted EBITDA was $79.1 million, or 30.4% of total revenues, compared to $81.4 million, or 34.2% of total revenues, in the prior year [10] Capital Allocation and Shareholder Returns - The company returned $30 million in share repurchases and $7 million in dividends during the quarter, demonstrating a commitment to returning capital to shareholders [12] - The company ended the quarter with total liquidity of approximately $550 million, including $124 million in cash and cash equivalents [14] Growth Outlook - The company updated its full-year 2025 financial guidance, expecting revenues to be in the range of $970 million to $990 million, reflecting approximately 10% growth at the midpoint [16] - The backlog expanded by 21.4% year-over-year to a record $1.3 billion, providing strong visibility into future revenue streams [1][3] Strategic Initiatives - The company is advancing its feasibility study for a new fully automated facility in Florida, aimed at addressing future growth needs and enhancing operational efficiency [15] - The opening of a California showroom is part of the company's West Coast expansion strategy, which is already showing positive order momentum [3]

Core Points - The article emphasizes the importance of enabling Javascript and cookies in browsers to prevent access issues [1] - It highlights that users with ad-blockers may face restrictions when trying to access content [1] Summary by Categories Technical Requirements - Users are advised to enable Javascript and cookies in their browsers to ensure proper functionality [1] - The presence of ad-blockers can lead to blocked access, necessitating their temporary disablement [1]

Core Points - Crédit Agricole S.A. has completed its share repurchase program, which started on 1 October 2025 and ended on 30 October 2025 [2] - A total of 22,886,191 shares were repurchased at an aggregate cost of 374,414,014 euros [2] - The purpose of the repurchase was to offset the dilutive effect of a capital increase reserved for employees, with the repurchased shares set to be cancelled [3] - The transaction resulted in a decrease of 9 basis points in Crédit Agricole S.A.'s CET1 ratio and a decrease of 6 basis points for the Crédit Agricole group [3] - The execution of the existing liquidity agreement with Kepler Cheuvreux was temporarily suspended during the share repurchase program and will now resume [4]

Core Insights - Altria Group, Inc. experienced a decline in share price due to a decrease in smokeable and oral tobacco sales, impacting year-over-year revenue growth [1][2] Financial Performance - The company reported third-quarter adjusted earnings per share of $1.45, reflecting a 3.6% increase year over year, aligning with analyst expectations [2] - Quarterly sales totaled $6.072 billion, down 3% year over year, but exceeded the analyst consensus of $5.309 billion [2] - Net revenues from smokeable and oral tobacco products decreased, with revenues net of excise taxes falling 1.7% to $5.3 billion [2][3] Segment Performance - Oral tobacco product revenues declined by 4.6% due to lower shipment volumes [3] - Smokeable product revenues decreased by 2.8%, attributed to softer volumes and increased promotional investments [3] Operational Highlights - Gross profit increased by 0.1% year over year to $3.812 billion, while operating income rose by 2.5% to $3.230 billion [4] - The company ended the quarter with cash and equivalents amounting to $3.472 billion [4] Shareholder Returns - The board expanded the share repurchase program to $2 billion, effective through December 31, 2026, contingent on market conditions [5] - The company aims for mid-single digits dividend per share growth annually through 2028 [5] Future Outlook - Altria raised its fiscal 2025 adjusted EPS outlook to a range of $5.37 to $5.45, slightly above the previous estimate [6] - The company anticipates moderated EPS growth in the fourth quarter due to the completion of the accelerated share repurchase program and the expiration of the Master Settlement Agreement legal fund [6] Market Reaction - Altria Group shares fell by 6.74% to $57.79 at the time of publication [7]